Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT00194714||Enrolling by invitation||Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab||
||Other / NIH||
||20||Female||19 Years and older (Adult, Senior)||NCT00194714||6304
|May 2016||November 2018||September 19, 2005||January 5, 2018||